We previously demonstrated that MSI-1436, a PTP1B allosteric inhibitor, protects against the development of atherosclerotic plaques in the LDLR(−/−) model of atherosclerosis, on a high-fat diet. This evidence concerns the gene LDLR and atherosclerosis.